ARCHIVES

40 Years Later: Doctor and Patient Reflect on the Cure

This article is from The Cancer Letter archive.

Vol. 40 No. 40 | October 24, 2014

Download PDF Visit The Full Archive

Related Articles

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

May 21, 1999

In Brief: ONS Invites Proposals For Research On Hazards Of Chemotherapy; UTSCC Adopts Code Of Ethics

August 31, 1984

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

Oxford Univ. Receives Funds To Create Drug Design Center.

October 6, 2000

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984

FDA Official Outlines agency’s Views On Efficacy Requirement

June 16, 1999